If TP53 mutations across tumor types produce a heterogeneous functional output, it is possible that mutants differ in the extent to which they inactivate wild type p53, serve as a DN, and/or produce oncogenic GOF activities that promote cancer beyond inactivating p53. Here, TP53 is linked to cancer.